Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

50.69
Delayed Data
As of Jul 31
 -0.08 / -0.16%
Today’s Change
39.28
Today|||52-Week Range
51.74
+12.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Operating ActivitiesNet Income / Starting Line539.0M904.0M2.3B--
 
 
 
 
Depreciation355.0M395.0M371.0M--
 
 
 
 
Total Other Cash Flow40.0M125.0M-2.7B--
 
 
 
 
Funds From Operations934.0M1.4B-10.0M--
 
 
 
 
Funds From/For Other Operating Expenses-267.0M186.0M-12.0M--
 
 
 
 
Net Cash Flow - Operating Activities1.2B1.2B2.0M--
 
 
 
 
 
InvestingIncrease In Investments---1.5B-213.0M--
 
 
 
Decrease In Investments2.2B2.3B----
 
 
 
Capital Expenditures-277.0M-287.0M-235.0M--
 
 
 
 
Fixed Asset Disposal----230.0M--
 
 
Net Assets From Acquisitions -2.8B-495.0M----
 
 
 
Other Investing - Sources35.0M13.0M13.0M--
 
 
 
 
Net Cash Flow Investing-825.0M-10.0M-205.0M--
 
 
 
 
 
FinancingShort Term Borrowings397.0M74.0M-1.5B--
 
 
 
 
Long Term Borrowings0.000.002.5B--
 
 
Long Term Debt Reduction0.00-577.0M-10.0M--
 
 
 
Net Proceeds Stock Sale64.0M139.0M156.0M--
 
 
 
 
Common Preferred Redeemed-1.0M-1.0M-1.3B--
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-331.0M-335.0M-364.0M--
 
 
 
 
Other Sources - Financing0.000.000.00----
Other Uses - Financing400.0M0.000.00--
 
 
Net Cash Flow - Financing-271.0M-700.0M-550.0M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-62.0M-78.0M-84.0M--
 
 
 
 
 
Net Change In Cash105.0M528.0M-753.0M0.00